Getinge ABGetinge ABGetinge AB

Getinge AB

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
0.18USD
Revenue estimate
‪733.94 M‬USD
Market capitalization
‪5.79 B‬USD
‪238.06 M‬USD
‪3.14 B‬USD
‪212.62 M‬
Beta (1Y)
1.81

About Getinge AB

CEO
Mattias Sven Perjos
Headquarters
Gothenburg
Employees (FY)
‪11.74 K‬
Founded
1990
ISIN
SE0000202624
FIGI
BBG000PSG912
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GNGBF is 21.25 USD — it has increased by 7.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Getinge AB stocks are traded under the ticker GNGBF.
Getinge AB is going to release the next earnings report on Jul 18, 2024. Keep track of upcoming events with our Earnings Calendar.
GNGBF stock is 7.27% volatile and has beta coefficient of 1.81. Check out the list of the most volatile stocks — is Getinge AB there?
GNGBF earnings for the last quarter are 0.31 USD per share, whereas the estimation was 0.32 USD resulting in a −4.37% surprise. The estimated earnings for the next quarter are 0.14 USD per share. See more details about Getinge AB earnings.
Getinge AB revenue for the last quarter amounts to ‪977.43 M‬ USD despite the estimated figure of ‪909.79 M‬ USD. In the next quarter revenue is expected to reach ‪709.03 M‬ USD.
Yes, you can track Getinge AB financials in yearly and quarterly reports right on TradingView.
GNGBF stock has risen by 7.84% compared to the previous week, the month change is a 7.35% rise, over the last year Getinge AB has showed a 14.07% decrease.
GNGBF net income for the last quarter is ‪42.87 M‬ USD, while the quarter before that showed ‪70.87 M‬ USD of net income which accounts for −39.51% change. Track more Getinge AB financial stats to get the full picture.
Today Getinge AB has the market capitalization of ‪5.79 B‬, it has decreased by 1.03% over the last week.
Yes, GNGBF dividends are paid annually. The last dividend per share was 0.41 USD. As of today, Dividend Yield (TTM)% is 1.83%. Tracking Getinge AB dividends might help you take more informed decisions.
Getinge AB dividend yield was 1.96% in 2023, and payout ratio reached 49.69%. The year before the numbers were 1.96% and 46.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GNGBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Getinge AB stock right from TradingView charts — choose your broker and connect to your account.
GNGBF reached its all-time high on Nov 15, 2021 with the price of 48.01 USD, and its all-time low was 8.75 USD and was reached on Jun 28, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has ‪11.74 K‬ employees. See our rating of the largest employees — is Getinge AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Getinge AB technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Getinge AB stock shows the sell signal. See more of Getinge AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Getinge AB future price: according to them, GNGBF price has a max estimate of 27.42 USD and a min estimate of 17.00 USD. Read a more detailed Getinge AB forecast: see what analysts think of Getinge AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Getinge AB EBITDA is ‪514.35 M‬ USD, and current EBITDA margin is 18.56%. See more stats in Getinge AB financial statements.